News

Stay current with the most recent news and events related to eye cancer, brought to you by The Eye Cancer Foundation.


The Eye Cancer Foundation Awarded 2021 Platinum Seal of Transparency by GuideStar

The Eye Cancer Foundation Awarded 2021 Platinum Seal of Transparency by GuideStar

June 11, 2021

For the second year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by GuideStar, the leading source of information on non-profits within the United States. The ECF is pleased that donors, current and prospective, are able to gain valuable insight into how we f... Read More

Presenting The Spring 2021 Visionary

Presenting The Spring 2021 Visionary

June 11, 2021

The Spring 2021 issue of The Eye Cancer Foundation’s Visionary magazine is now available! The Eye Cancer Foundation publishesThe Visionaryfree-of-charge to keep you informed about the latest news, research and global efforts focused on improving eye cancer treatment, diagnosis and cures. In this ed... Read More

Patient Story: Eye Saved From Enucleation Through Eye Cancer Network

Patient Story: Eye Saved From Enucleation Through Eye Cancer Network

May 19, 2021

It comes as no question eye cancer care is not readily available in all corners of the world, hence the work and mission of The Eye Cancer Foundation. This is especially true of countries in the Middle East, where more aggressive forms of treatment may be the only option for otherwise treatable case... Read More

ECF Supported Research Featured in New York Eye and Ear Infirmary 200 Years Celebration

ECF Supported Research Featured in New York Eye and Ear Infirmary 200 Years Celebration

May 13, 2021

The New York Eye and Ear Infirmary of Mount Sinai is celebrating 200 years of providing innovative, first-class care to patients with ocular diseases. At the core of the infirmary’s Ocular Oncology Service stands ECF Executive Director Paul T. Finger, MD who doubles as the committee’s founding direc... Read More

Patients Presenting with Stage IV Metastatic Uveal Melanoma Examined in New ECF Supported Study

Patients Presenting with Stage IV Metastatic Uveal Melanoma Examined in New ECF Supported Study

April 5, 2021

Uveal melanoma is classified as Stage IV when there are metastasis. A multicenter, international collaborative registry study was recently published in the British Journal of Ophthalmology. Therein, eye cancer professionals examined the ocular and systemic findings of patients presenting with Stage ... Read More

The ECF Sponsors New Study Assessing Ophthalmic Radiation Therapy Outcomes

The ECF Sponsors New Study Assessing Ophthalmic Radiation Therapy Outcomes

March 29, 2021

Alongside the Myrna and John Daniels Fund at the Princess Margaret Cancer Center, The Eye Cancer Foundation is proud to co-sponsor the Study of Ophthalmic Radiation Therapy Toxicity (SORTT). Through the international, multicenter study, eye cancer sites across the world will assess patient outcomes ... Read More

Ciliary Body Leiomyoma and Melanoma Can Appear Identical as Found in Research Supported by The Eye Cancer Foundation

Ciliary Body Leiomyoma and Melanoma Can Appear Identical as Found in Research Supported by The Eye Cancer Foundation

March 18, 2021

In a new study published to the American Journal of Ophthalmology Case Reports, eye cancer professionals identified biopsy with immunohistochemical pathology analysis as the only method that can differentiate between certain leiomyoma and uveal melanoma. According to the study, the two ocular disea... Read More

Save Sight and Life This Valentine's Day

Save Sight and Life This Valentine's Day

February 4, 2021

This Valentine's Day, The Eye Cancer Foundation is asking you to take part in our digital campaign, #Eye♥TheECF. In order to continue pioneering research, offering fellowships and supporting patients, we need your help. We want you to share why you love The ECF on social media and ask your network o... Read More

The ECF Recognizes Recently Published Research on Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma

The ECF Recognizes Recently Published Research on Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma

January 15, 2021

In a recent study published in Clinical Ophthalmology, eye care specialists examined conservative routes of treatment for group D retinoblastoma patients. As its classification suggests, group D tumors are more advanced in form. In developing countries particularly, this equates to more aggressive f... Read More

The 2020 Annual Appeal

The 2020 Annual Appeal

November 23, 2020

We need you now more than ever! As aresult of The Eye Cancer Foundation’s 2020 Campaign you have helped us train eye cancer specialists in 25 countries where patients had no access to specialty care. That means, the children with eye cancer in those countries now have a chance not to go blind or di... Read More

Top Stories

Follow Us Online